RNA Therapeutics Institute; Program in Molecular Medicine, Department of Molecular, Cell and Cancer Biology; Li Weibo Institute for Rare Diseases Research; Graduate School of Biomedical Sciences
Genetic Phenomena | Genetics and Genomics | Nucleic Acids, Nucleotides, and Nucleosides
Two new studies refine our understanding of CRISPR-associated exon skipping and redefine its utility in engineering alternative splicing.
Rights and Permissions
© The Author(s). 2018 Open Access: This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
DOI of Published Version
Genome Biol. 2018 Nov 6;19(1):184. doi: 10.1186/s13059-018-1565-3. Link to article on publisher's site
Smith JL, Mou H, Xue W. (2018). Understanding and repurposing CRISPR-mediated alternative splicing. Open Access Articles. https://doi.org/10.1186/s13059-018-1565-3. Retrieved from https://escholarship.umassmed.edu/oapubs/3668
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.